TTEC:NASDAQTTEC Holdings, Inc. Analysis
Data as of 2026-05-28 - not real-time
$2.64
Latest Price
8/10Risk
Risk Level: High
Executive Summary
TTEC is trading at $2.64, far below its DCF fair value of $6.58, suggesting a material upside. However, the stock sits under its 20‑day (2.69) and 50‑day (2.74) SMAs, the RSI hovers around 48, and volume is on a decreasing trend, all pointing to a bearish technical backdrop. The MACD shows a marginal bullish signal but the histogram is near zero, so momentum remains weak.
Fundamentally, revenue slipped 7% YoY to $496 M and the company posted a loss per share of $4.18, yet forward EPS of $1.25 and a forward PE of ~2.1 indicate earnings could rebound. Management is emphasizing a >40% offshore mix and AI‑driven CX services to lift margins, but the balance sheet is strained with a debt‑to‑equity ratio exceeding 950% and a negative ROE, adding significant financial risk.
Fundamentally, revenue slipped 7% YoY to $496 M and the company posted a loss per share of $4.18, yet forward EPS of $1.25 and a forward PE of ~2.1 indicate earnings could rebound. Management is emphasizing a >40% offshore mix and AI‑driven CX services to lift margins, but the balance sheet is strained with a debt‑to‑equity ratio exceeding 950% and a negative ROE, adding significant financial risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings miss and negative profit margin
- Technical weakness: price below key SMAs and decreasing volume
- High short‑term volatility and bearish trend direction
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap to DCF fair value
- Forward EPS positivity and low forward PE
- Strategic shift toward offshore mix and AI‑enabled CX services
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Long‑term growth potential in the CX technology market
- Undervalued relative to industry PE multiples
- Potential margin improvement if offshore/AI initiatives succeed
Key Metrics & Analysis
Financial Health
Revenue Growth-7.10%
Profit Margin-9.60%
P/E Ratio2.1
ROE-100.97%
ROA3.65%
Debt/Equity956.55
P/B Ratio1.3
Op. Cash Flow$127.0M
Free Cash Flow$91.7M
Industry P/E40.4
Technical Analysis
TrendBearish
RSI48.1
Support$2.36
Resistance$3.11
MA 20$2.69
MA 50$2.74
MA 200$3.16
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$6.58
Target Price$4.00
Upside/Downside51.52%
GradeUndervalued
TypeValue
Risk Assessment
Beta2.06
Volatility80.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.